Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT02794285. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicentre, Randomised, Double-blind, Placebo-Controlled Phase 3 Extension Study to Characterise the Long-term Safety and Tolerability of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to characterise long-term safety and tolerability of intravenous anifrolumab.
Study identification
- NCT ID
- NCT02794285
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 559 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2016 (Actual)
- Primary completion
- Dec 21, 2021 (Actual)
- Completion
- Dec 21, 2021 (Actual)
- Last update posted
- Jan 13, 2023
2016 – 2021
United States locations
- U.S. sites
- 62
- U.S. states
- 23
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35294-3280 | — |
| Research Site | El Cajon | California | 92020 | — |
| Research Site | Hemet | California | 92543 | — |
| Research Site | La Jolla | California | 92037 | — |
| Research Site | Los Alamitos | California | 90720 | — |
| Research Site | Los Angeles | California | 90024 | — |
| Research Site | San Leandro | California | 94578 | — |
| Research Site | Thousand Oaks | California | 91360 | — |
| Research Site | Upland | California | 91786 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Denver | Colorado | 80230 | — |
| Research Site | Bridgeport | Connecticut | 06606 | — |
| Research Site | Brandon | Florida | 33511 | — |
| Research Site | DeBary | Florida | 32713 | — |
| Research Site | Miami | Florida | 33136 | — |
| Research Site | Miami | Florida | 33180 | — |
| Research Site | Ormond Beach | Florida | 32174 | — |
| Research Site | Tampa | Florida | 33614 | — |
| Research Site | Vero Beach | Florida | 32960 | — |
| Research Site | Atlanta | Georgia | 30322 | — |
| Research Site | Decatur | Georgia | 30033 | — |
| Research Site | Lawrenceville | Georgia | 30046 | — |
| Research Site | Marietta | Georgia | 30060 | — |
| Research Site | Boise | Idaho | 83702 | — |
| Research Site | Idaho Falls | Idaho | 83404 | — |
| Research Site | Cumberland | Maryland | 21502 | — |
| Research Site | Hagerstown | Maryland | 21740 | — |
| Research Site | Grand Rapids | Michigan | 49546 | — |
| Research Site | Minneapolis | Minnesota | 55455-0341 | — |
| Research Site | Nashua | New Hampshire | 03060 | — |
| Research Site | Freehold | New Jersey | 07728 | — |
| Research Site | Las Cruces | New Mexico | 88011 | — |
| Research Site | Brooklyn | New York | 11201 | — |
| Research Site | Great Neck | New York | 11021 | — |
| Research Site | New Hyde Park | New York | 11042 | — |
| Research Site | New York | New York | 10016 | — |
| Research Site | New York | New York | 10021 | — |
| Research Site | New York | New York | 10032 | — |
| Research Site | Charlotte | North Carolina | 28210 | — |
| Research Site | Charlotte | North Carolina | 28277 | — |
| Research Site | Greenville | North Carolina | 27834 | — |
| Research Site | Raleigh | North Carolina | 27617 | — |
| Research Site | Middleburg Heights | Ohio | 44130 | — |
| Research Site | Oklahoma City | Oklahoma | 73102 | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Philadelphia | Pennsylvania | 19140 | — |
| Research Site | Pittsburgh | Pennsylvania | 15213 | — |
| Research Site | Reading | Pennsylvania | 19610 | — |
| Research Site | North Charleston | South Carolina | 29406 | — |
| Research Site | Memphis | Tennessee | 38104 | — |
| Research Site | Memphis | Tennessee | 38119 | — |
| Research Site | Amarillo | Texas | 79124 | — |
| Research Site | Austin | Texas | 78726 | — |
| Research Site | Austin | Texas | 78745 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | Houston | Texas | 77004 | — |
| Research Site | Houston | Texas | 77034 | — |
| Research Site | Houston | Texas | 77074 | — |
| Research Site | Mesquite | Texas | 75150 | — |
| Research Site | Stafford | Texas | 77477 | — |
| Research Site | Spokane | Washington | 99204 | — |
| Research Site | Milwaukee | Wisconsin | 53217 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 113 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02794285, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2023 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02794285 live on ClinicalTrials.gov.